PDS BIOTECHNOLOGY CORP (PDSB)

US70465T1079 - Common Stock

3.61  +0.26 (+7.76%)

After market: 3.63 +0.02 (+0.55%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
43.05M41.67M21.44M14.90M15.01M
Research and Development
27.76M29.43M11.25M7.92M6.10M
Selling, General, and Administrative Expenses
15.28M12.24M10.18M6.96M8.91M
Operating Income
-43.05M-41.67M-21.44M-14.90M-15.01M
Interest Income/Expense
-1.30M-380.00K0.0060.00K320.00K
Other Income/Expense
N/A0.00N/AN/A0.00
Non Recurring Items
N/AN/AN/A0.007.31M
Income Before Taxes
-44.35M-42.05M-21.43M-14.85M-7.38M
Income Tax
-1.41M-1.20M-4.52M0.00-380.00K
Net Income
-42.94M-40.85M-16.92M-14.85M-7.00M
EBITDA
-42.99M-41.62M-21.43M-14.88M-14.91M
 
Per Share Data
EPS Diluted Total Ops
-1.39-1.43-0.66-0.89-1.44
Non GAAP EPS
-1.39-1.45-0.63-0.99N/A
 
Statistics

All data in USD

Charts